Fulgent Genetics, Inc.FLGTNASDAQ
Loading
Enterprise value to EBITDA ratio
Percentile
P36
Within normal range
vs 5Y Ago
-4.4x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -16.56 | -58.5% |
| 2024 | -10.45 | -97.8% |
| 2023 | -5.28 | -234.4% |
| 2022 | 3.93 | -4.1% |
| 2021 | 4.10 | +8.1% |
| 2020 | 3.79 | -97.3% |
| 2019 | 138.21 | +899.5% |
| 2018 | -17.29 | +57.4% |
| 2017 | -40.60 | -143.1% |
| 2016 | 94.16 | - |